Terns Pharmaceuticals CEO Senthil Sundaram's 2021 pay falls 77% to $3.1M
Terns Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Terns Pharmaceuticals reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at Terns Pharmaceuticals received on average a compensation package of $2.1M, a 70% decrease compared to previous year.
Average pay of disclosed executives at Terns Pharmaceuticals
Senthil Sundaram, Chief Executive Officer, received $3.1M in total, which decreased by 77% compared to 2020. 73% of Sundaram's compensation, or $2.3M, was in option awards. Sundaram also received $39K in bonus, $295K in non-equity incentive plan, $514K in salary, as well as $2.5K in other compensation.
Erin Quirk, Chief Medical Officer, received a compensation package of $1.7M, which decreased by 56% compared to previous year. 61% of the compensation package, or $1M, was in option awards.
Bryan Yoon, Chief Operating Officer, earned $1.5M in 2021, a 54% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2022.